TP53 and cancer: Our analysis of canine visceral HSAs found that the tumor suppressor TP53 was the most frequently mutated gene (14/15 cases, 93%; Fig. 2A); all but one of the mutations occurred in the DNA-binding domain, which is the most frequently mutated domain in TP53 in human cancers (Laptenko and Prives, 2006).